Our Grantees

chuan he

Chuan He, Ph.D.

The University of Chicago Improving the Efficiency of Alkylation Anticancer Chemotherapies...more

Craig Okada, M.D.

Oregon Health & Science University Tumor Antigen Receptor Vaccines for Active Immunotherapy of T Cell Malignancies...more

Daisuke Nakada, PhD

Baylor College of Medicine Metabolic regulation of leukemia stem cells...more

Daniel Starczynowski, Ph.D.

Cincinnati Children's Hospital Defining the role and therapeutic potential of TNF receptor-associated factor 6 in Myelodysplastic Syndromes...more

david frank

David Frank, M.D., Ph.D.

Dana-Farber Cancer Institute The Development of STAT Inhibitors as Novel Anti-Leukemia Agents: Use of Semi-Random Synthesis Technology...more

david sternberg

David W. Sternberg, M.D., Ph.D.

Mount Sinai School of Medicine Translational Regulation of Gene Expression in Acute Myelogenous Leukemia (AML)...more

dawn lemanne

Dawn Lemanne, M.D., MPH

Memorial Sloan-Kettering Cancer CenterA Randomized Trial of Physical-Activity Motivation in Breast Cancer Patients....more

sipkins11

Dorothy Sipkins, M.D., Ph.D.*

The University of ChicagoRegulation of Leukemia Cell Dormancy by the Bone Marrow Microenvironment...more

douglas graham

Douglas K. Graham, M.D., Ph.D.

University of Colorado Health Sciences Center Mer Tyrosine Kinase as a Cooperative Oncogene in Leukemogenesis...more

yang2

Eddy Shih-Hsin Yang, M.D., Ph.D.

University of Alabama-Birmingham Comprehensive Cancer Center Mechanisms by which GSK3β inhibition enhances nonhomologous end-joining repair of IR-induced double strand breaks...more

elizabeth hexner

Elizabeth Hexner, M.D.

Hospital of the University of PennsylvaniaT cells to Enhance Umbilical Cord Blood Transplantation...more

eric carnes

Eric C. Carnes, Ph.D.

University of New Mexico Cancer Research & Treatment Center Targeted Nanotherapeutics for Treatment of Acute Leukemia...more

Evripidis Gavathiotis, Ph.D.

Albert Einstein College of Medicine Targeting Anti-Apoptotic BHRF-1: A Novel Therapeutic Strategy for Epstein-Barr Virus Associated Lymphomas...more

Fay Young, M.D.

University of Rochester Medical Center Integrin and Chemokine-Mediated Homing During B Cell Ontogeny and Leukemogenesis...more

Gabriel Birrane, Ph.D.

Beth Israel Deaconess Medical Center Investigating the role of the ROBO1 protein in the development of blood cancers...more

Gang "Greg" Wang, PhD

University of North Carolina, Lineberger CCC Novel Approaches to Target PRC2 Enzymatic Complexes for the Treatment of Hematopoietic Malignancies...more

george georges

George Georges, M.D.

Fred Hutchinson Cancer Research Center T-Cells to Control the Graft-Versus-Host Effect of Nonmyeloablative Hematopoietic Cell Transplantation...more

greg beatty

Gregory L. Beatty, M.D., Ph.D.

University of Pennsylvania Medical Center Targeting inflammation within the tumor microenvironment for cancer therapy...more

lacorazza2

H. Daniel Lacorazza, Ph.D.

Baylor College of Medicine Role of proliferation in the pathogenesis of T-cell acute lymphoblastic leukemia...more

hao huang

Hao Huang, Ph.D.

The University of Chicago Study of the inhibitory role of miR-26 in the development of MLL-associated leukemia...more